For the Quarter Ending September 2024
North America
In Q3 2024, the pricing landscape for Neomycin Sulphate in North America displayed a mixed trend, with the most pronounced fluctuations occurring in the U.S. market. Initially, prices experienced a decline, followed by a mid-quarter increase, only to decrease again as the quarter came to a close.
The initial price drop was influenced by several factors exerting downward pressure on the market. Recent economic data revealed a consistent decline in inflation over the past five months, which contrasted sharply with the rapid price increases seen earlier in the year. However, the middle of the quarter brought a surge in consumer confidence and an economic rebound, which significantly heightened demand for Neomycin Sulphate. This increased demand tightened the balance between supply and demand, leading to a temporary price rise. Concerns regarding potential supply chain disruptions, particularly related to port strikes and congestion at overseas ports, added to the urgency. Importers rushed to secure inventory, further exacerbating supply constraints and pushing prices upward. Additionally, early Christmas demand prompted retailers to engage in proactive stockpiling, which further tightened supply availability. Despite this brief uptick, prices faced another decline in September due to a combination of factors affecting both supply and demand dynamics. A notable decrease in new orders, driven by a general weakening in demand and growing political uncertainty surrounding the upcoming presidential election in November, led consumers to adopt a more cautious spending approach.
As the quarter concluded, Neomycin Sulphate was priced at USD 11,950 per metric ton (USP, FDA) CFR New York, reflecting the fluctuations and complexities of the market throughout the quarter.
Asia Pacific
In Q3 2024, the Neomycin sulphate market in the APAC region exhibited a varied pricing trend influenced by several key factors. At the beginning of the quarter, prices experienced a decline in July, primarily driven by sluggish consumption levels both domestically and internationally. The Chinese market, in particular, faced a downturn as demand weakened, exacerbated by limited support from downstream sectors. Additionally, rising freight costs, fueled by disruptions in global maritime traffic, significantly impeded international demand for Neomycin sulphate. As the quarter progressed, however, a shift in market dynamics occurred, leading to a rebound in prices. This upward trend was supported by robust demand from end-user industries, alongside effective inventory management strategies implemented by market participants. The global economic recovery efforts further bolstered this price increase, contributing to an overall positive outlook in the market. Despite this mid-quarter surge, prices began to decline again as the quarter came to a close, influenced by a confluence of adverse market dynamics. Insufficient demand became a key concern, marked by a noticeable drop in new orders, particularly in exports. The appreciation of the Chinese yuan against the USD also played a significant role, as it made exports more expensive for foreign buyers, thereby reducing foreign demand and applying additional downward pressure on prices.
Europe
In Q3 2024, the European market for Neomycin sulphate experienced a mixed pricing trend, shaped by a variety of interconnected factors. Initially, prices rose steadily through the first half of the quarter, buoyed by consistent demand from end-users, which laid a solid foundation for price growth. The easing of inflation in Germany, which dropped to 2% annually, also played a significant role in this upward momentum by alleviating some financial pressures on consumers. This decline in inflation enhanced consumer purchasing power, positively influencing the demand for pharmaceuticals, including Neomycin sulphate dihydrate. However, as September approached, a significant downturn began to manifest. A key factor contributing to this decline was a marked drop in demand, representing the steepest decrease seen in recent months. In response to this weakening demand, market participants moved quickly to adjust their pricing strategies, leading to widespread price reductions aimed at stimulating sales. This proactive response only served to accelerate the downward trend in Neomycin sulphate prices, creating a challenging environment for suppliers as they navigated the shifting market dynamics. Overall, the quarter was characterized by an initial period of growth followed by a sharp decline, reflecting the complex interplay of demand, consumer sentiment, and economic conditions across the European market.
For the Quarter Ending June 2024
North America
In Q2 2024, Neomycin Sulphate pricing in North America experienced a mixed trajectory, reflecting diverse market dynamics. The quarter saw an initial increase in prices, followed by a mid-period decline, and a subsequent rise towards the end.
In April, prices rose due to a surge in domestic demand. Consumers, undeterred by cost fatigue, displayed a willingness to spend, leading to stronger retail sales and a higher demand for Neomycin Sulphate. However, prices fell in the middle of the quarter as demand softened. The decrease in new orders and a contracting order backlog indicated a gradual economic slowdown. Additionally, the Federal Reserve's decision to maintain high interest rates, aimed at stabilizing inflation, inadvertently eroded consumer purchasing power, adding pressure to prices. Prices rebounded in June due to increased cargo import volumes at U.S. ports. Retailers ramped up stock levels to meet rising demand, especially as they approached the peak shipping season. This boost in import activity contributed to the upward trajectory in prices.
The percentage change from the previous quarter in 2024 was 4%, indicating a slight upward trend. However, a comparison between the first and second half of the quarter showed no significant variation in prices, underscoring the stability of the market. The latest quarter-ending price of Neomycin Sulphate (USP, FDA) CFR New York in the USA stood at USD 11890/MT.
Asia Pacific
In Q2 2024, the Neomycin Sulphate market in the APAC region exhibited fluctuating pricing trends. The quarter began with an increase in prices in April, driven by a boost in market confidence. Manufacturers in China capitalized on heightened demand by increasing production and inventory levels, reflecting a positive business outlook. However, prices fell in May as market sentiment weakened. Businesses faced challenges from diminishing consumer demand and growing financial pressures, impacting overall market conditions. In June, prices rebounded due to improved domestic demand and a rise in inquiries from key sectors such as pharmaceuticals and healthcare. The demand from international markets also remained strong, contributing to a steady increase in prices throughout the month. This uptick highlighted the resilience of the market amidst earlier challenges. Manufacturers faced rising input costs, largely due to escalating crude oil prices and increased prices for raw materials. These higher input costs were inevitably passed on to consumers in the form of higher Neomycin Sulphate prices. Overall, the quarter demonstrated a varied pricing environment for Neomycin Sulphate in the APAC region, marked by initial increases, a mid-period decline, and a final recovery.
Europe
The second quarter of 2024 has seen a robust upward trajectory in Neomycin Sulphate prices across Europe, driven by several converging factors that have shaped the market dynamics. The eurozone's economic resurgence bolstered business activity, leading to heightened demand for Neomycin Sulphate among end-users. The unexpected spike in consumer demand prompted companies to urgently restock inventories, further intensifying market pressure. Geopolitical disruptions, notably the Red Sea crisis, coupled with seasonal port congestion in key Asian hubs, created substantial logistical bottlenecks, exacerbating supply constraints and inflating shipping costs. Focusing on Germany, the nation experienced the most pronounced price fluctuations within the region. The German market's robust economic recovery, marked by increased business confidence and consumer spending, significantly influenced Neomycin Sulphate prices. The interplay of stronger-than-anticipated demand, compounded by logistical challenges, resulted in a marked price increase. Seasonal factors, such as spikes in cargo volumes around holidays, further accentuated these trends. Compared to the same quarter last year, prices surged considerably, reflecting the compounded effects of these variables. The quarter's overall pricing environment has been decisively positive, underscored by a 4% increase from the previous quarter and a notable 3% rise between the first and second halves of the quarter. The latest quarter-ending price for Neomycin Sulphate in Germany stood at USD 12905/MT. This consistent upward trend highlights the strong correlation between market demand, supply chain disruptions, and economic factors, firmly establishing the quarter as a period of significant price escalation for Neomycin Sulphate.
For the Quarter Ending March 2024
North America
In Q1 2024, the pricing of Neomycin Sulphate in the North America region underwent significant fluctuations influenced by various factors. Overall, the pricing environment for Neomycin Sulphate in this quarter remained positive, with prices experiencing a continuous increase throughout. A key driver behind these market fluctuations was the heightened demand from downstream industries, particularly pharmaceuticals and healthcare. Increased buying activity in these sectors led to upward pressure on Neomycin Sulphate prices.
Furthermore, the spring festival in China prompted proactive inventory replenishment by market retailers and distributors, further boosting demand for the drug. On the supply side, challenges in transportation logistics due to adverse weather conditions and disruptions at vital shipping chokepoints constrained the supply chain, exacerbating the upward pressure on prices. In response to potential shortages, market players were placing large orders for Neomycin Sulphate to ensure supply continuity and preempt delays, further fueling demand and pushing prices higher.
Overall, the pricing environment for Neomycin Sulphate in Q1 2024 was characterized by positivity, albeit with fluctuations driven by changes in demand and supply dynamics. The quarter-ending price for Neomycin Sulphate in the USA stood at USD 11,600 per metric ton (USP, FDA) CFR New York.
Asia Pacific
In Q1 2024, the pricing of Neomycin Sulphate in the APAC region underwent significant fluctuations influenced by various factors, resulting in notable price changes. Overall, the market sentiment has been positive, with prices witnessing a consistent incline throughout the quarter. This positive momentum marked a significant turnaround from the challenges encountered in the fourth quarter of 2023, which included subdued end-user demand, limited new inquiries, and surplus inventory. However, starting from January 2024, there was a steady rise in demand, which continued to gain momentum through March, signaling a recovery in market sentiment. The first quarter of 2024 witnessed marked improvement, characterized by rising prices, indicating a more balanced relationship between supply and demand. This upward trend enabled participants in the Chinese market to maintain healthy profit margins throughout the quarter. Even during the Lunar Chinese New Year holidays, the domestic Neomycin Sulphate market remained vibrant, supported by robust manufacturing activities and the availability of fresh inventory. Furthermore, the global demand for Neomycin Sulphate, particularly from the pharmaceutical and other sectors, added layers of complexity to the supply-demand dynamics, further influencing market trends. As the quarter draws to a close, the latest recorded price for Neomycin Sulphate (USP, FDA) FOB Shanghai in China stands at USD 10,550 per metric ton.
Europe
During Q1 2024, Neomycin Sulphate pricing in the European region underwent significant fluctuations due to a multitude of factors shaping the market dynamics. The surge in demand for Neomycin Sulphate was primarily fueled by seasonal patterns and a boost in consumer confidence. This increased demand, combined with logistical challenges and disruptions in the supply chain, led to a constrained availability of the medication, fostering a bullish market sentiment overall. Germany, in particular, experienced substantial price changes for Neomycin Sulphate during this period. In January, heightened demand from the pharmaceutical sector, driven by seasonal factors such as winter-related ailments, drove prices upwards. Additionally, the onset of the Chinese New Year festivities in mid-February prompted many Chinese suppliers to adjust their prices ahead of the market slowdown during the holiday period. Simultaneously, prolonged disruptions in the Red Sea further complicated trade routes between Asia and Europe, resulting in increased freight costs that influenced the pricing landscape of Neomycin Sulphate in Germany. Furthermore, the moderation of inflation in Germany led to heightened spending by businesses and consumers, contributing to further price hikes. Looking ahead, the market outlook remains optimistic, with prices anticipated to continue increasing. In conclusion, the quarter-ending price for Neomycin Sulphate in Germany stood at USD 12365/MT CFR Hamburg, reflecting the culmination of these market dynamics.
For the Quarter Ending December 2023
North America
The fourth quarter of 2023 witnessed a challenging period for Neomycin Sulphate pricing in the North America region. Several factors impacted the market and prices during this period. Firstly, the ongoing high interest rates and inflationary pressures affected consumer purchasing power, leading to decreased demand for Neomycin Sulphate in the pharmaceutical and healthcare sectors. Secondly, the geopolitical tensions and trade disputes between major economies, such as the United States and China, disrupted the supply chain and led to higher transportation costs, further impacting the pricing of Neomycin Sulphate. Lastly, the availability of alternatives in the market also contributed to the subdued demand for Neomycin Sulphate.
In the USA, the largest market for Neomycin Sulphate in North America, the prices experienced a decline in the fourth quarter of 2023. The high interest rates and inflation, coupled with the geopolitical tensions, affected consumer confidence and limited their spending capacity. Additionally, the availability of cost-effective imports from major exporting countries like China further contributed to the decline in prices. In terms of price trends, there was a significant decrease of 14% in Neomycin Sulphate prices compared to the same quarter of the previous year. Furthermore, there was an 11% decrease in prices from the previous quarter, indicating the downward trajectory of Neomycin Sulphate prices. The price comparison between the first and second half of the quarter showed a 4% decrease, reflecting the overall downward trend in pricing.
In conclusion, the Neomycin Sulphate market in the North America region, particularly in the USA, faced challenges in the fourth quarter of 2023 due to high interest rates, inflation, geopolitical tensions, and increased availability of alternatives. These factors led to a decline in prices, impacting the overall market dynamics. The quarter ending price of Neomycin Sulphate (USP, FDA) CFR New York in the USA was USD 11025/MT.
APAC
The Neomycin Sulphate market in the APAC region during the fourth quarter of 2023 witnessed several key factors that impacted prices. Firstly, the overall market was bearish, with weak demand both domestically and internationally. This was primarily due to a decline in manufacturing activity, particularly in China, which is the largest player in the market. The Chinese manufacturing sector contracted for the second consecutive month in November, leading to a surplus of supply and intense market competition. Additionally, the global economic uncertainty caused by geopolitical tensions, such as the Israel-Hamas conflict, further dampened demand for Neomycin Sulphate. In terms of supply, there was a moderate to high availability of Neomycin Sulphate in the Chinese market, as manufacturers faced a lack of substantial orders and intense competition. The pricing trend in China for Neomycin Sulphate showed a bearish trend, with a decrease in prices from October to December. In conclusion, the Neomycin Sulphate market in the APAC region during the fourth quarter of 2023 was impacted by weak demand, surplus supply, and intense market competition. The latest price of Neomycin Sulphate (USP, FDA) FOB Shanghai in China for the current quarter is USD 10000/MT.
Europe
During the fourth quarter of 2023, the pricing of Neomycin Sulphate in the European region was influenced by various factors. Prices experienced a decline throughout the quarter, attributed to a combination of prevailing subdued consumer sentiments, elevated high-interest rates, and ample supply availability in the market. In Germany, where notable changes in Neomycin Sulphate prices occurred, market dynamics were shaped by a reduction in inflation rates, primarily driven by favorable base effects and a decrease in energy prices. Despite this, high-interest rates continued to restrict consumer spending, curtailing overall demand and impacting Neomycin Sulphate prices. During the fourth quarter of 2023, the price of Neomycin Sulphate in Germany decreased by 11% compared to the previous quarter. Furthermore, there was a significant decrease of 29% in prices compared to the same quarter of the previous year. The price percentage comparison between the first and second half of the quarter showed a decline of 4%. Overall, the European Neomycin Sulphate market experienced decreased prices primarily influenced by diminished demand from both the pharmaceutical and healthcare sectors. The market was additionally influenced by high interest rates, which limited consumer spending and affected the prices of Neomycin Sulphate. The quarter ending price of Neomycin Sulphate (USP, FDA) CFR Hamburg in Germany for the current quarter is USD 11850/MT.
For the Quarter Ending September 2023
North America
The neomycin sulphate prices showcased a significantly declining trend of 13.22 percent in July but rose by 1.67% and 1.89% in the month of August and September, respectively. In July, inquiries for new orders and sales also declined as domestic and foreign demand conditions remained subdued. The Federal Reserve raised its key policy interest rate by a quarter of a percentage in July, the highest level in 22 years, which, in turn, reduced overall demand in the economy, supporting a downward trajectory. However, the prices increased in August and September with the surge in energy prices, which drove up the overall business expenses and shipping costs, leading to an increase in neomycin sulphate prices. The gasoline prices climbed as Russia and Saudi Arabia maintained aggressive supply cuts, pushing crude oil to a 10-month high of $91 per barrel. Additionally, imports from important exporting countries like China decreased, reducing the supply of neomycin sulphate in the US market and driving up prices. Inventory replenishment was a top priority for market participants, which has also contributed to the rise in neomycin sulphate prices.
Asia Pacific
The neomycin sulphate prices showcased a significantly declining trend of 13.20 percent in July but rose by 1.38% and 1.82% in the month of August and September, respectively. The prices of Neomycin Sulphate continued to decline in July with the slowdown of factory activity amid a fall in demand from downstream industries. The official manufacturing PMI (Purchasing Managers Index) came in at 49.3 in July, indicating a contraction of factory activity for the fourth consecutive time in July as China's amid lower overseas orders and insufficient domestic demand. Neomycin sulphate prices increased in the month of August and September as a result of an improvement in demand outlook from end-consumers amid limited supply in the market due to continued contraction of the manufacturing sector for the fifth time in a row. Furthermore, China's central bank lowered its key interest rate amid economic concerns, which helped to boost market consumption, raising neomycin sulphate prices in China. China's manufacturing purchasing managers' index (PMI) gracefully surged back into the expansive realm in September, illuminating the resumption of factory activity and heralding a promising economic resurgence within the nation.
Europe
The neomycin sulphate prices showcased a significantly declining trend of 13.83 percent in July but rose by 1.68% and 1.81% in the month of August and September, respectively. Neomycin Sulphate prices declined in July due to a slowdown in business activity amid a decrease in downstream industry demand. The sharp decrease in the demand for goods can be attributed to a variety of factors, including customer reluctance, destocking, and higher interest rates, along with tightening market conditions as well as economic and geopolitical uncertainties. The prices inclined in August and September due to persistent inflation, high-interest rates, and the energy crisis. The German inflation rate was +6.1% in August, expressed as the year-over-year change in the consumer price index (CPI). Food and energy prices have risen faster than overall inflation, keeping inflation high. Energy product prices rose 8.3% year on year, following a 5.7% increase in July. Because of the consistently high inflation, businesses' expenses for maintaining APIs (Active Pharmaceutical Ingredients) rise, contributing to higher neomycin sulphate prices in Germany.
For the Quarter Ending June 2023
North America
In the United States, Neomycin Sulphate prices showcased a mixed trend in the second quarter. The prices rose 0.29% in May due to increased end-user demand coupled with new inventory replenishment activities, keeping the market situation favorable. The manufacturing PMI (Purchasing Managers Index) hit 48.4 in May, indicating a slowdown in the US manufacturing sector. This shows that supply from manufacturers and suppliers has been constrained due to reduced business activity. However, consumer demand remained strong, leading to higher Neomycin Sulphate prices in May. On the other hand, prices fell 0.69% in June from May due to sluggish offtakes across end-user industries. Domestic suppliers have adequate Neomycin Sulphate stockpiles, leading to continuously falling costs in the domestic market. Furthermore, high Federal Reserve interest rates have reduced demand for Neomycin Sulphate in the market, further supporting the downtrend. In addition, the US dollar's appreciation against the Chinese yuan in June increased imports to the US market, increasing the supply, which further put downward pressure on neomycin sulphate prices.
Asia Pacific
Neomycin sulphate prices in China showed different trends in the second quarter. Neomycin Sulphate prices rose 0.44% in May from April levels due to the persistence of domestic demand and ongoing operations activity. China's purchasing managers' index (PMI) fell to 48.8 in May from 49.2 in April, signaling a slowdown in factory activity, leading to a reduction in inventories among manufacturers and market suppliers to meet strong market demand, pushing prices higher. In contrast, the price of neomycin sulphate fell 0.83% in June from May due to the decline in new orders and consumer purchasing activity. The official PMI for the manufacturing sector rose to 49.0 in June from 48.8 in the previous month, signaling a slowdown in manufacturing activity. Production decreased due to weak demand from end users. However, prices are kept low as market participants hold enough inventory to meet current market demand. In addition, China's exports fell 12.4% in June, leading to an increase in neomycin sulphate availability in the Chinese market, supporting the downtrend.
Europe
In Germany, the situation of the Neomycin Sulphate market showed a mixed trend throughout the second quarter. The price of Neomycin Sulphate rose slightly in May to 0.34% from April, then fell to 7.62% in June. Prices rose in May due to limited inventories among traders and suppliers, coupled with increased demand from end-user industries. Germany's manufacturing purchasing managers' index (PMI) fell to 43.2 in May from 44.5 in April, reflecting weaker business activity, lower inventories of market participants, and delays in deliveries to meet market demand, leading to higher neomycin sulphate prices. In June, the German economy was impacted by rising inflation and an interest rate hike by the European Central Bank, resulting in higher food and energy prices. This has increased the cost of living and reduced consumer purchases, supporting the downtrend in prices of neomycin sulphate. In addition, the appreciation of the Euro against the US dollar in June made imports cheaper and also increased the supply of neomycin sulphate in the German market. This resulted in decreased prices of Neomycin Sulphate.
For the Quarter Ending March 2023
North America
Throughout the first quarter, the prices of Neomycin Sulphate inclined in North America on account of Strong market sentiment, which started to develop for Neomycin Sulphate across the USA in early January and continued throughout the end of March due to continuous orders from domestic buyers. Also, traders encountered the costliest import from China as the Chinese currency gained against the US dollar, appreciating nearly 3% in January alone, keeping the prices in the northward direction. Moreover, consistent orders from the end-user sector kept the market trend for Neomycin Sulphate on the sturdy side until the end of this quarter. With this, the prices of Neomycin Sulphate went in the upward direction with a settlement of USD 13800/MT in the United States.
APAC
In the APAC region, Neomycin Sulphate prices, particularly in China, demonstrate an incremented trend as the first quarter of 2023 ends. In the month of January, Neomycin Sulphate prices significantly increased on the back of healthy demand from the pharmaceutical and healthcare sectors. The end-user markets from the domestic as well as the international technically resumed on a bullish note with a boost in orders after the Lunar New Year vacation. Moreover, the market sentiments somewhat improved in China during the holiday-shortened month of January, primarily in anticipation of growing demand from downstream sectors as both consumption and production increased when the government abandoned its zero-COVID policy. Following this trend from February until March also, the prices of Neomycin Sulphate increased at a moderate level, mostly brought on by the steadily rising demand and consistent inquiries from end-user sectors. With this, the cost of Neomycin Sulphate ended the first quarter with a price settlement of USD 12488/MT in China.
Europe
Neomycin Sulphate market trends in Europe in the first quarter of 2023 were comparable. The market trend started on the stronger side and continued throughout the month of March. In Germany, the price of Neomycin Sulphate grew at a high pace in early January due to an improvement in market sentiments. Also, German consumer prices improved more than expected in February because of lowering inflation and decreased energy costs, which progressively enhanced consumer confidence. Additionally, improved trade activity further supported the positive market sentiments throughout the first quarter of 2023. With this, the cost of Neomycin Sulphate was assembled at USD 15990/MT in the German Market.
For the Quarter Ending December 2022
North America
The Q4 of 2022 saw a decline in the price of Neomycin Sulphate in the North American market, with CFR New York prices settling at USD 14315/MT in October due to weak demand from the downstream pharmaceutical industry in the United States. Despite low domestic consumption rates, production rates were maintained at their optimum levels. However, these costs dropped further in November, to USD 13250/MT in December on the domestic US market. As the US economy finally began to recover and the port on the east coast dramatically decreased ship backlogs, the US supply chain steadily improved in H2 of 2022. Because of the decreased shipping demand caused by slower consumer spending and a decline in industry activity, the US supply chains were more flexible, resulting in a dip in product prices.
Asia- Pacific
Neomycin Sulphate prices in the Asia-Pacific region continued their downward trend throughout the fourth quarter of 2022, falling to USD 11900/MT in December after settling at USD 12750/MT in October due to weak demand from downstream pharmaceutical industries. The Golden week closure of industrial facilities in China from October 1 and 7 resulted in a slow rate of contraction in the manufacturing sector this month. The recurrence of Covid cases at the end of October caused logistical restrictions and end-user run rate limitations, which led to a buildup of Neomycin Sulphate inventory and reduced offers. In addition, prices decreased as consumers continued to purchase products they needed amid the domestic market's declining demand.
Europe
Not just in North America and Asia Pacific region, the Neomycin Sulphate market in the European region also witnessed relatively similar market dynamics, where the prices declined in the fourth Quarter of 2022. German Neomycin Sulphate saw a dip in market sentiments, with CFR Hamburg prices assessing at USD 16580/MT in October before falling even more in December to USD 15318/MT as domestic demand was lower than expected, especially from the primary end-user pharmaceutical industry, due to pessimistic market sentiments. Market insiders held a bearish mentality because of low import quotations from Asian countries. Additionally, high stock levels forced dealers to deliberately lower their prices in order to empty their limitless inventories. Additionally, when port congestion concerns subsided, the cost of shipping goods from Asia to Europe was also reduced.
For The Quarter Ending September 2022
North America
The Neomycin Sulphate market witnessed a stable trend in the North American region in the third quarter of 2022. The market was steady due to steady demand and surplus availability of inventories, impacting the price dynamics of Neomycin Sulphate in the region. However, removing the lockdown in the exporting countries and production resumption kept the supply chain firm in the regional and overseas markets. Also, demand from the downstream pharmaceutical and other industries has declined throughout Q3 2022. Weak market sentiments compelled domestic merchants to lower their quotations to encourage more end-user enquires. Towards the end of Q3 of 2022, Neomycin Sulphate prices were assessed at USD 15520/MT for CFR New York.
Asia- Pacific
Neomycin Sulphate prices fluctuated in the Asia- Pacific region throughout the third Quarter of 2022. During July and August, prices of Neomycin Sulphate have showcased an upward trajectory in the Chinese market, backed by a lowered rate of supplies and a disrupted supply chain. The reason behind the limited availability of the product across the regional market was frequent lockdown restrictions, the shutdown of facilities for maintenance, and problems related to power outages. Towards the end of Q3, prices dropped by 1.1%, supported by sufficient stockpiles in the region as production in facilities was restarted. Also, demand from the downstream industries remained stable to weak amid the slowdown in China's economy. As a result, prices of Neomycin Sulphate FOB Shanghai were assessed at USD 14100/MT during September.
Europe
In the European region, the price trend of Neomycin Sulphate showcased a marginal increase in the first half of the 3rd quarter of 2022 due to balanced market dynamics. However, prices stabilized at USD 18240/MT in August and declined in the latter weeks of the quarter. Therefore, stagnant behavior in price trends was due to numerous factors, such as the stable supply of inventories in the domestic market and moderate demand from the end-user pharmaceutical sector. However, by the H2 of Q3, the market situation started to change due to excessive stocks and decreasing demand, which further affected the product price trend. Thus, the prices for Neomycin Sulphate CFR Hamburg settled at USD 17950/MT in September 2022.
For the Quarter Ending June 2022
North America
The North America Neomycin Sulfate market showed a rise in prices in the first half and got stable by the second half of Q2 2022 due to the fluctuations between supply and demand. In the first half of the quarter, the costs of Neomycin Sulfate in the United States were increased due to the lower inventory level and the decline in imports from China. Because of the rising inflationary pressures and supply-chain disruptions supported the prices. Later from the second half of the quarter, imports from China improved as China lifted the area's lockdown and slowly returned to the normal market in mid-quarter. And for some reason, purchasers' interest waned, leading most buyers to withdraw and adopt a wait-and-see strategy, only purchasing when necessary. The CFR New York prices for Neomycin Sulfate were assessed at USD 15540/MT in the United States at the end of the quarter.
Asia- Pacific
During the second quarter of 2022, the prices of Neomycin Sulfate in China showcased fluctuations in the Asia-Pacific region due to mixed market sentiments with frequent changes in supply-demand dynamics. With the onset of a quarter, FOB prices continued to rise to 7% and were recorded at USD 13600/MT in April due to a strict lockdown from 28th March in Shanghai, which halted the manufacturing units and affected the production rate in the regional market. Furthermore, amidst the Russia and Ukraine war coupled with the shutdown in China, local manufacturers have been facing a limited supply to cater to domestic demand. In the H2 of Q2, prices decreased up to USD 13000/MT as manufacturers started exporting existing stockpiles at lower costs and reached USD 13440/MT by the end of the quarter due to improve in demand from downstream pharmaceutical industries.
Europe
In the second quarter of 2022, North America's Neomycin Sulfate API prices surged due to inadequate supply and increased demand fundamentals. Supply chain disruptions due to the Russia-Ukraine invasion have severely hampered trading activities, resulting in higher freight charges and escalating costs in the quarter. Higher offtakes from the downstream pharmaceutical sector have pressured the Neomycin Sulfate market sentiments in the regional market. The prices in the European market have increased by 2.9%, supported by a declination toward inventories of Neomycin Sulfate has substantially affected market value. As a ripple effect, the prices of Neomycin Sulfate API in Germany settled at USD 18000/MT.
